MarketBeat provided average rating data for the stock, and Citigroup began coverage on Whitehawk Therapeutics shares.
2 reports, 2 independent
Updated Sat 00:00
No new developments lately
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat provided average rating data for the stock, and Citigroup began coverage on Whitehawk Therapeutics shares.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Leerink Partners added coverage of Whitehawk Therapeutics.1 source
Citigroup started coverage of Whitehawk Therapeutics, with MarketBeat reporting average rating data.1 source
Keep exploring
The entities involved
-
MarketBeat
American personal finance blog
- Jefferies Financial Group began coverage, Morgan Stanley set a high price target, and Keefe, Bruyette & Woods increased price objectives, with MarketBeat reporting the average stock rating.
- Scotiabank raised its price target and Bank of America upgraded its rating on May 27, 2026, with MarketBeat aggregating the data.
-
Citigroup
American investment bank and financial services corporation
Related events
- Citigroup boosted its price target and gave a buy rating for Wholesale Club, with MarketBeat providing consensus data.
- Co-Diagnostics filed a stock purchase with the SEC and received stock rating data from MarketBeat.
- MarketBeat reported the stock's average rating while Citigroup reiterated a buy rating and Cantor Fitzgerald restated an overweight rating for Beta Technologies.
- MarketBeat provided average stock rating data for SS Innovations International, Inc. on June 6, 2026.
- Citigroup lifted its price target and gave a buy rating for Timken Company, with MarketBeat providing consensus data.